chrisvoncsefalvay/vaers-outcomes huggingface dataset:
2nd dose received 40 days after 1st dose. Within first 24 hours: Fever/Chills next morning. Stomach/body pain. Head pain.  Pain radiating to testicles.  Entire body aching.  Couldn't find comfortable position to sit/stand/walk.   Worse than any illness I've had, but without the brain fog Within next 48 hours: Armpit swollen on right arm (same as vaccine arm).  Pain in head persisting.  Pain behind ears.  Dizzy/lightheaded feeling. Third Day after vaccine: Armpit is still swollen.  Headache persists.  Ache in muscles and joints seem to be re-emerging.  But, overall, I'm fine and can work today. Note: Pollen count high - and I typically do get headaches from pollen - so, headaches could be attributable to pollen, but timing is suspicious.
1600: malaise 2200: body aches, chills, skin sensitivity, headache 0000: profuse diaphoresis, retching, dizziness, light-headedness 0020: chills, body aches, headaches unrelieved with 1G Tylenol 0200: profuse diaphoresis, retching, nausea, dizziness 0220: chills, body aches, skin sensitivity  0500: profuse diaphoresis, body aches, retching, dizziness 0515: chills, body aches, skin sensitivity 0730: profuse diaphoresis, retching, body aches, dizziness, anxiety 0745: fatigue, severe headache, chills, body aches. Take 1G Tylenol and 600mg ibuprofen drink 1 liter of water over next two hours. Sleep intermittently.  Tylenol, ibuprofen and water are continued until 2/15/2021  1600: 2/14/21 urticaria noted to right upper arm at injection site.  50mg Benadryl taken; topical halobetasol applied; urticaria triples in size @ 2200 50mg Benadryl taken again. Body aches are resolved. Headache is much improved but persists.  Urticaria almost completely resolved @ 2000 2/15/21. Other than mild headache other symptoms resolved.
Small bruising in the area of the flu shot site. Nausea - all day since 7am. Vomiting - 3pm and 6pm. Fever - 3:30pm (99.4), 5:00pm (100.3), 6:00pm (101). Took two Tylenol at 5:30pm then vomited 1/2 hour later. Went to ER at 6:30pm - received IV drip and Zofran.
A consumer report received from MHRA concerning a 3 year old male. The patient medical history and concomitant medication were not provided. The patient had received nasal FLUENZA TETRA, 0.2 milliliters, on 20-OCT-2015. The patient experienced chills, watery eyes, sneezing, headache, and funny nose which started on 22-OCT-2015. At the time of reporting, the event of chills, water eyes, sneezing, headache and runny nose was improving. The report assessed the events chills, watery eyes, sneezing, headache and runny nose to be serious due to important medical event.
3 days after initial vaccine dose, c/o tachycardia and palpitations that came and went.
This spontaneous report as received from a certified medical assistant refers to a patient of unknown demographics. On an unknown date, the patient was vaccinated with a dose of improperly stored GARDASIL (Lot number, expiry date, route and dose were not reported). The certified medical assistant reported that the vaccine was exposed to temperature of 26 F(Fahrenheit)for a total of 135 hours. No adverse effects reported. Follow-up received. Certified Medical assistant stated that other 104 children received GARDASIL. Follow up information has been received from the certified medical assistant regarding a 10 years old, male patient with no pertinent medical history reported. On 11-SEP-2012 the patient was vaccinated with the first dose of GARDASIL (lot number and expiration date not reported) (intramuscular on the left arm, dose not reported). It was reported that the patient did not seek medical attention. This is one of the several reports from the same source. Additional information is not expected.
from the injection point to elbow, patient said her arm is swollen, red, and painful. Patient went to the doctor and was told it looked like a reaction many patients experience and that it will get better.
No other AE no PQC reported; Inappropriate dose of vaccine administered; causing some of the medication to leak out; The patinet did not get the full dose of PROQUAD due to possible human error of not placing the office supplied needle on the office supplied syringe correctly; This spontaneous report was received from a physician concerning a 4-year-old patient of unknown gender. Information regarding the patient's concomitant therapies, current conditions, medical history and historical drug was not provided.   On 08-APR-2021, the patient was vaccinated with Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD) 1 dosage form lot number T012418 rHA expiration date 06-OCT-2021 (route of administration was not provided) as prophylaxis.  On the same date and during administration, it was reported that the patient did not get the full dose of Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD) due to possible human error of not placing the office supplied needle con the office supplied syringe correctly, causing some of the medication to leak out, after withdrawing the medication from the vial. The reported confirmed that there was nothing wrong with the vial or vaccine.  Lot No. T012418 has been verified to be a valid lot number for Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD), reported as 26-OCT-2021, but upon internal validation established as 06-OCT-2021.
Severe chills lasting 4-5 hours, reduced blood flow to fingertips, upset stomach. Started recovering around 6 PM. Pharmacy tech had stated this was same flu vaccine and manufacturer patient had received previously.
Booster was given 4 months early Dose 1 administered 9/15/21 Dose 2 administered 10/7/21
Rash onset 14 days after immunization/vaccine, box 5 Generalized Vaccinia.
swollen glands were on the same side where you had the injection; muscle aches; joint pain; swollen lynph node under her arm which eventually went away; soreness in left arm at injection site; was very tired; supra clavicular node which has not gone away; discoloration on 2 of her of bottom teeth on the left side; This spontaneous case was reported by an other health care professional and describes the occurrence of LYMPHADENOPATHY (supra clavicular node which has not gone away), TOOTH DISCOLOURATION (discoloration on 2 of her of bottom teeth on the left side), LYMPHADENOPATHY (swollen glands were on the same side where you had the injection), MYALGIA (muscle aches) and ARTHRALGIA (joint pain) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 29-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Dec-2020, the patient experienced TOOTH DISCOLOURATION (discoloration on 2 of her of bottom teeth on the left side). On an unknown date, the patient experienced LYMPHADENOPATHY (supra clavicular node which has not gone away), LYMPHADENOPATHY (swollen glands were on the same side where you had the injection), MYALGIA (muscle aches), ARTHRALGIA (joint pain), LYMPHADENOPATHY (swollen lynph node under her arm which eventually went away), INJECTION SITE PAIN (soreness in left arm at injection site) and FATIGUE (was very tired). The patient was treated with PARACETAMOL (TYLENOL) at a dose of UNK, prn and IBUPROFEN (ADVIL [IBUPROFEN]) at a dose of UNK, prn. At the time of the report, LYMPHADENOPATHY (supra clavicular node which has not gone away) had not resolved, TOOTH DISCOLOURATION (discoloration on 2 of her of bottom teeth on the left side), MYALGIA (muscle aches), ARTHRALGIA (joint pain), INJECTION SITE PAIN (soreness in left arm at injection site) and FATIGUE (was very tired) outcome was unknown and LYMPHADENOPATHY (swollen glands were on the same side where you had the injection) and LYMPHADENOPATHY (swollen lynph node under her arm which eventually went away) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Most recent FOLLOW-UP information incorporated above includes: On 10-Jan-2021: No specific follow-up information recorded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Medication was given by mistake as a Intradermal injection. MA thought it was a PPD
The area on left deltoid is red (5.5cmX7cm) swollen and itching after receiving influenza vaccination. Child is afebrile.
scheduled to receive second dose on 28Apr2021 which is on day 41 after first dose; Poison ivy around eyes; This spontaneous case was reported by a consumer and describes the occurrence of DERMATITIS CONTACT (Poison ivy around eyes) and INTENTIONAL PRODUCT USE ISSUE (scheduled to receive second dose on 28Apr2021 which is on day 41 after first dose) in a 58-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006B21A) for COVID-19 vaccination.     Concomitant products included SIMVASTATIN and LEVOTHYROXINE for an unknown indication.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Apr-2021, the patient experienced DERMATITIS CONTACT (Poison ivy around eyes). On 14-Apr-2021, the patient experienced INTENTIONAL PRODUCT USE ISSUE (scheduled to receive second dose on 28Apr2021 which is on day 41 after first dose). The patient was treated with PREDNISONE (oral) ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, DERMATITIS CONTACT (Poison ivy around eyes) outcome was unknown and INTENTIONAL PRODUCT USE ISSUE (scheduled to receive second dose on 28Apr2021 which is on day 41 after first dose) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Most recent FOLLOW-UP information incorporated above includes: On 23-Apr-2021: followup received on 23-apr-2021: concomitant and treatment medications,new events were added
6/5  slight pain in neck   ibuprofen 6/6   a little more pain in neck   ibuprofen 6/7  excruciating Pain in neck could not move   got a Cervical Collar/Neck brace took  ibuprofen and found some old cyclobenzaprine 5mg  and ice packs on neck 6/8  Same as 6/7 6/9 Feeling better can now move neck but chin to chest still hurt a little
In the evening after receiving vaccines - pt started to have hives (approx 6) on sides of face & neck sites were also warm & red. Called ER & was instructed to give BENADRYL. Hives resolved. Hives reappeared on 12/31/11. Gave BENADRYL & hive disappeared again. Had 2 more episodes of hives on 1/1/12 & 1/2/12 & started on ZYRTEC.
Narrative:  Patient reported lightheadedness following vaccine administration. Patient required no intervention and was able to depart on own.
This spontaneous report was received from a medical assistant refers to an unknown number of patients of unknown age. The medical history, concurrent conditions and concomitant medications were not reported. On an unknown date, the patients were vaccinated with ROTATEQ lot # M007124, 05-OCT-2017, temperature 49.6F for 108 hours 4mins. It was administered and there was no previous temperature excursion. No adverse effects were reported. Additional information has been requested.
COVID-19 mRNA LNP-S, bivalent PF 6mos-5yrs (Moderna), 10 mcg/0.2 mL - wrong dose given- (under dosed)
This spontaneous case reported by a consumer, describes the occurrence of peripheral swelling (little swelling in left arm), paresthesia (tingling/feet tingling), pain in extremity (pain in left arm), dizziness and asthenia (weak) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 017B21A) for COVID-19 vaccination. The occurrence of additional events detailed below. Concurrent medical conditions included anxiety and depression. Concomitant products included (Prozac) fluoxetine hydrochloride for anxiety and depression. On Mar 31, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On Mar 31, 2021, patient experienced peripheral swelling (little swelling in left arm), paresthesia (tingling/feet tingling), pain in extremity (pain in left arm), dizziness, asthenia (weak) and fatigue (tired). On Mar 31, 2021, peripheral swelling (little swelling in left arm), paresthesia (tingling/feet tingling), pain in extremity (pain in left arm), dizziness, asthenia (weak) and fatigue (tired) resolved. The action taken with mRNA-1273 (Moderna COVID-19 vaccine): unknown. The reporter did not provide any causality assessments or treatment medication.
Information has been received from a male consumer with a Vicodin Tablet allergy and a history of fungus growth in the lung (1997) who on 1/31/02 at 09:00 was vaccinated with the 1st dose (lot 640577/0995L) of pneumococcal vaccine 23 polyvalent. Concomitant therapy on 1/31/02 included Lipitor, Zestril, omeprazole; Zyban; nicotine patch; Viagra; Atrovent; Slo-Bid and vitamins (unspecified). On 1/31/02, about 4 hours after vaccination, the pt's arm began to hurt. He reported that this became worse later in the afternoon. His arm also became swollen later that day. He noted that as of 2/1/02, the swelling and pain were somewhat reduced. Unspecified medical attention was sought. Additional information has been requested.
ADMINISTERED 2.5ML OF THE VACCINE; OFF LABEL USE; This spontaneous report received from a health care professional concerned a 42 year old female. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1822809, and expiry: 07-MAR-2022) 2.5 ml, administered on 21-NOV-2021 for prophylactic vaccination. No concomitant medications were reported.  On 21-NOV-2021, the patient experienced administered 2.5ml of the vaccine. On 21-NOV-2021, the patient experienced off label use. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the administered 2.5ml of the vaccine and off label use was not reported. This report was non-serious. This case, from the same reporter is linked to 20211219926, 20211220206, 20211220129, 20211220552, 20211220916, 20211220152, 20211219681, 20211220262, 20211220250, 20211220155, 20211220129, 20211219926, 20211165041, 20211220145, 20211202199, 20211202161, 20211201450, 20211201443, 20211201392, 20211201351, 20211201304, 20211220619, 20211200723, 20211200752, 20211200769, 20211201046, 20211201228, 20211201963, 20211202193, 20211202207, 20211202246, 20211202250, 20211202371, 20211200675, 20211200717, 20211220697 and 20211220928.
brain bleeds; headache; This is a spontaneous report from a contactable consumer (patient). A 55-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as 1st dose, single (at the age of 55-year-old) for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient stated that she had brain bleeds on an unspecified date. She had had no headache. The patient stated that she had one (referring to headache) after the vaccine that lasted for three days. She was going to get the second vaccine on 04May2021. The patient did not know if this triggered another bleed. The patient stated that the doctor has not ordered a scan to check if she has had another bleed. The patient did not know if she should get the second dose or not, and wanted to know if it was safe to get the second dose or if it was related to vaccine. The outcome of event headache was recovered, and of the other event was unknown.  Information on the lot/ batch number has been requested.
warm at the injection site; mild sore throat; "flu-like" symptoms; pain in the arm; redness , a red circle; chills; tiredness; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (warm at the injection site), OROPHARYNGEAL PAIN (mild sore throat), INFLUENZA LIKE ILLNESS ("flu-like" symptoms), PAIN IN EXTREMITY (pain in the arm) and VACCINATION SITE ERYTHEMA (redness , a red circle) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No significant historical event reported.).    On 13-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage form. On 22-Mar-2021, the patient experienced VACCINATION SITE WARMTH (warm at the injection site), OROPHARYNGEAL PAIN (mild sore throat), INFLUENZA LIKE ILLNESS ("flu-like" symptoms), PAIN IN EXTREMITY (pain in the arm), VACCINATION SITE ERYTHEMA (redness , a red circle), CHILLS (chills) and FATIGUE (tiredness). At the time of the report, VACCINATION SITE WARMTH (warm at the injection site), OROPHARYNGEAL PAIN (mild sore throat), INFLUENZA LIKE ILLNESS ("flu-like" symptoms), PAIN IN EXTREMITY (pain in the arm), VACCINATION SITE ERYTHEMA (redness , a red circle), CHILLS (chills) and FATIGUE (tiredness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       There was no concomitant list.  Treatment was not provided.
This spontaneous report as received from a Registered Nurse (RN) refers to an unspecified number of college students of unknown age and gender. The patient's medical history and concurrent conditions were not reported. On unknown dates the patient were vaccinated with the first dose of GARDASIL. Information on dose, route and lot number was not provided. No concomitant medications were reported. The nurse reported that the patients were behind schedule with receiving either their second or third doses of GARDASIL and their remaining doses of an unspecified hepatitis B vaccine (manufacturer unknown) due to being away at college. No adverse symptoms reported. Additional information has been requested.
Swollen Cheek; Swollen lips; This is a spontaneous report received from a contactable consumer, the patient. A 77-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; lot number: EL3249), via an unspecified route of administration in the left arm on 25Jan2021 at 12:15 (at the age of 77-years-old), as a single dose for COVID-19 immunisation. The patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; lot number: EN6200), via an unspecified route of administration in the left arm on 15Feb2021 at 15:15 (at the age of 77-years-old), as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had no known allergies. The patient did not receive any other vaccination within four weeks prior to the COVID-19 vaccine. The patient did not receive any other medication within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 27Jan2021 at 09:00 (after receiving the first dose of COVID-19 vaccination), the patient experienced swollen cheek and lip. On an unknown date 2 weeks and 4 weeks, (after second dose of COVID-19 vaccination) the patient experienced swollen cheek and lip. The events resulted in doctor or other healthcare professional office/clinic visit. The patient was treated with prednisone and anti-histamine for the events. The clinical outcome of the events swollen cheek and lip was resolved on an unknown date.   No follow-up attempts are needed. No further information is expected.
3/4/11-Started having high fever & falling down; 03/7/11-Saw Dr., Red Red & Rash; 3/22/11-Walking better, now no problems.
Had temp of 104; was told by MD to give APAP & continued w/routine immun;
multiple patients were vaccinated with improperly stored VAQTA on multiple dates; no adverse effect; This spontaneous report was received from a medical assistant refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 10-JAN-2019, the patient was vaccinated with improperly stored hepatitis a vaccine, inactivated(VAQTA) lot # R002086, expiry date 22-APR-2019 for prophylaxis.  No adverse event was reported. Previous temperature excursion was reported. Data logger was involved.
pt reported she has hives that started at injection site and increased to generalized all over body and took approximately 4-5 days to clear up with OTC medication when she returned for her second dose. Pt didn't receive the second dose and was told to contact her primary care provider to discuss risk vs. benefits of receiving second dose and also verbal information about anaphylaxis was shared with the patient.
Client c/o not feeling right, fever 102 on/off increased heart rate, dizziness on 7/14/06 pm out of town. Called on call MD who evaluated, client called on 7/17/06 with all stated info, as per client MD gave aspirin B/P not checked told pt heart rate is 20 times faster then normal must be from vaccines. Instructed to go to ER or MD for complete assessment.
Dizziness, diarrhea, extreme fatigue, body aches, inflamation of  PREVIOUSLY injured areas of body, fever of 101 for consecutive days, zevere headache, arm swole and redness from injection site to wrist, continued mental fog and confusion.
Received expired dose of the Moderna vaccine/vaccine given 6 days post expiry; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received expired dose of the Moderna vaccine/vaccine given 6 days post expiry) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 046C21A and 041L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Nov-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (Received expired dose of the Moderna vaccine/vaccine given 6 days post expiry). On 12-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Received expired dose of the Moderna vaccine/vaccine given 6 days post expiry) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were provided by the reporter. No treatment medications were provided by the reporter.   This case was linked to MOD-2021-395985.
6 days post vaccine small circular rash appeared approximately 2-3cm below injection site. Following day rash was bigger and now solid, hot to touch and itchy. Over the course 6 days the rash has continued to spread down and up my arm in a circular shape. Lymph node located in my armpit also became swollen a day after the rash appeared.  I saw the doctor on the 4th day after the rash had appeared. That doctor consulted with dermatology and infectious disease. They are saying that it is a "site" related reaction. Recommendation for treatment is OTC allergy med, ibuprofen and ice.  I'm 12 days post first vaccine and 6 days post start of rash and it's still ongoing.